Ericsson announces proposed headcount reduction in Sweden
STOCKHOLM, Jan. 15, 2026 /PRNewswire/ -- Ericsson (NASDAQ: ERIC) today announces proposed staff reductions in Sweden as part of measures aimed at ensuring the Company's competitive position. The proposed staff reduction is part of global initiatives...
Immunofoco Presents Phase I/IIa Data of IMC002 at ASCO GI 2026, Highlighting a Durable Complete Response Beyond One Year and a 66.7% ORR in Advanced GC/GEJ
SHANGHAI, Jan. 13, 2026 /PRNewswire/ -- Immunofoco, a clinical-stage biotechnology company advancing innovative CAR-T cell therapies for solid tumors, recently announced clinical data from its Phase I/IIa study of IMC002, a VHH-based anti-CLDN18.2...
RWA.LTD Launches Vietnam Market Expansion: Using Ho Chi Minh City as a Strategic Hub to Explore Southeast Asia Deployment Pathways for Non-Financial RWA
HONG KONG, Dec. 30, 2025 /PRNewswire/ -- Against the backdrop of real-world asset (RWA) digitization gradually moving from concept to practical application worldwide, Southeast Asia is emerging as a key frontier for the next wave of innovation and...
Dato' Seri Ir. Dr. Zaini Ujang's conferred the 'Professor Emeritus' title in conjunction with MK69 UTM
Distinguished UTM alumnus and national leader honoured for his leadership, scholarship, and impact on global standing. JOHOR BAHRU, Malaysia, Dec. 22, 2025 /PRNewswire/ -- After an illustrious 37-year career in academia and public service, Dato'...
High Response in Bladder Cancer: Immvira Announced Its MVR-T3011 Latest Clinical Results in BCG-Unresponsive Bladder Cancer Patients at 2025 Annual Meeting of the Society of Urologic Oncology
SUZHOU, China, Dec. 4, 2025 /PRNewswire/ -- On December 3, 2025 (local time in Arizona, USA), ImmVira Group ("ImmVira" or the "Company") announced a poster presentation at the 26th Annual Meeting of the Society of Urologic Oncology (SUO 2025). The...
The Annals of Oncology Publishes Results of Phase II Study of Sacituzumab Tirumotecan Monotherapy for Urothelial Carcinoma
CHENGDU, China, Nov. 28, 2025 /PRNewswire/ -- Recently, Clinical study results from Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech", HKEX: 6990)'s TROP2 ADC sacituzumab tirumotecan (sac-TMT) monotherapy for advanced or metastatic...
JSAUX Kicks Off Black Friday Event with Major Savings on Gaming Accessories
HONG KONG, Nov. 20, 2025 /PRNewswire/ -- Tech manufacturer JSAUX has initiated its annual Black Friday promotion , offering discounts on various gaming peripherals and accessories. The sale is available through both the company's official website...
First Flock of 19 Whooper Swans Arrives in Rongcheng for Winter
WEIHAI, China, Nov. 3, 2025 /PRNewswire/ -- A news report from CRI Online: The first flock of 19 whooper swans has been spotted at Rongcheng Swan Lake, marking the official start of the swan season in the coastal city. Staff at the Rongcheng...
Zhimeng Biopharma's investigational drug CB03-154 for amyotrophic lateral sclerosis has achieved the first patient first dose milestone in the phase 2/3 pivotal clinical trial.
SHANGHAI, Oct. 31, 2025 /PRNewswire/ -- Shanghai Zhimeng Biopharma Inc. ( "Zhimeng") announced that its self-developed new-generation potassium channel opener CB03-154 for the treatment of amyotrophic lateral sclerosis (ALS) has officially initiated...
MetaOptics Announces Strategic Expansion into the USA with Nevada Incorporation and Advanced 127μm Co-Packaged Optics Breakthrough
SINGAPORE, Oct. 29, 2025 /PRNewswire/ -- MetaOptics Ltd (Catalist: 9MT) ("MetaOptics"), a leading-edge semiconductor optics company pioneering metalens technology, is pleased to announce the establishment of its United States entity, MetaOptics Inc....